New to Generics Bulletin?
Request a free trial today!
Register for our free email digests:
Register for our free email digests:
Akriti Seth
Senior Reporter
London, UK
As a correspondent for Channel NewsAsia, Singapore and for India Technology News, Akriti has covered a wide range of subject-matter including politics, economics and technology for a B2B audience. She has also gained experience working for Bloomberg TV India and Mid-Day Mumbai. Akriti is a graduate of the University of Mumbai and holds a masters from Mumbai's Xavier Institute of Communications. Most recently she has worked as a freelance journalist in London, where she is now based, having lived there for the past two years. She enjoys photography and blogging.
Advertisement
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Akriti Seth
Alkem Grows At Home And Abroad
Alkem said it had a “mixed year”, registering growth in India and internationally despite setbacks that included a weak anti-infectives season and a recent Form 483 from the US Food and Drug Administration.
Alvotech Reels In Abdi Ibrahim For Access To Turkey
In a move to take its pipeline of biosimilar monoclonal antibodies global, Alvotech has struck a deal with Abdi Ibrahim that will give it localization advantages in Turkey.
GMP Suspension Finally Lifted From Bristol Labs
After recent inspections, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has fully reinstated Good Manufacturing Practice (GMP) status for Bristol Laboratories’ UK manufacturing sites, enabling the firm to resume complete supply to the UK market.
Advertisement